- Home
- RVMD vs CFR Comparison
RVMD vs CFR Comparison
Compare RVMD & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- CFR
- Stock Information
- Founded
- RVMD 2014
- CFR 1868
- Country
- RVMD United States
- CFR United States
- Employees
- RVMD N/A
- CFR N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- CFR Major Banks
- Sector
- RVMD Health Care
- CFR Finance
- Exchange
- RVMD Nasdaq
- CFR Nasdaq
- Market Cap
- RVMD 7.5B
- CFR 8.1B
- IPO Year
- RVMD 2020
- CFR N/A
- Fundamental
- Price
- RVMD $65.84
- CFR $124.10
- Analyst Decision
- RVMD Strong Buy
- CFR Hold
- Analyst Count
- RVMD 17
- CFR 16
- Target Price
- RVMD $77.24
- CFR $138.44
- AVG Volume (30 Days)
- RVMD 2.4M
- CFR 498.2K
- Earning Date
- RVMD 11-05-2025
- CFR 10-30-2025
- Dividend Yield
- RVMD N/A
- CFR 3.21%
- EPS Growth
- RVMD N/A
- CFR 20.47
- EPS
- RVMD N/A
- CFR 9.72
- Revenue
- RVMD N/A
- CFR $2,141,575,000.00
- Revenue This Year
- RVMD N/A
- CFR $13.87
- Revenue Next Year
- RVMD $537.73
- CFR $4.09
- P/E Ratio
- RVMD N/A
- CFR $12.82
- Revenue Growth
- RVMD N/A
- CFR 9.02
- 52 Week Low
- RVMD $29.17
- CFR $100.31
- 52 Week High
- RVMD $65.98
- CFR $147.64
- Technical
- Relative Strength Index (RSI)
- RVMD 84.78
- CFR 49.05
- Support Level
- RVMD $58.91
- CFR $122.32
- Resistance Level
- RVMD $63.15
- CFR $127.08
- Average True Range (ATR)
- RVMD 2.19
- CFR 2.78
- MACD
- RVMD 0.40
- CFR 0.29
- Stochastic Oscillator
- RVMD 98.46
- CFR 63.68
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $50 billion in assets (as of mid-2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.